Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
uniQure N.V. - Ordinary Shares
(NQ:
QURE
)
50.47
-0.58 (-1.14%)
Streaming Delayed Price
Updated: 1:17 PM EDT, Aug 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about uniQure N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
July 29, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure to Announce Second Quarter 2026 Financial Results
July 22, 2026
~ uniQure to host earnings call on Wednesday, July 29, 2026 at 8:30 a.m. ET ~
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
June 25, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Pricing of Upsized $225 Million Public Offering
June 23, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces $150 Million Proposed Public Offering
June 22, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
June 19, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
June 17, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
May 05, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
April 30, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure to Announce First Quarter 2026 Financial Results
April 28, 2026
From
uniQure Inc.
Via
GlobeNewswire
QURE CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
April 13, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
April 13, 2026
From
Schall Law
Via
GlobeNewswire
uniQure N.V. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against uniQure N.V. - QURE
April 10, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
QURE Deadline: Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
April 10, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
UNIQURE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th
April 10, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
April 09, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
April 09, 2026
From
Schall Law
Via
GlobeNewswire
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
April 07, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
April 07, 2026
From
Pomerantz LLP
Via
GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.
April 07, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
April 06, 2026
From
Schall Law
Via
GlobeNewswire
UNIQURE N.V. (NASDAQ: QURE) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 13, 2026
April 06, 2026
From
Berger Montague
Via
GlobeNewswire
uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights
April 03, 2026
From
Robbins LLP
Via
Business Wire
UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE
April 02, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th
April 02, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline
April 02, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
QURE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
April 02, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
April 02, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
April 02, 2026
From
Schall Law
Via
GlobeNewswire
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
March 31, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
